Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany - PubMed (original) (raw)
Clinical Trial
. 2000 Mar;85(3):1059-65.
doi: 10.1210/jcem.85.3.6441.
Affiliations
- PMID: 10720040
- DOI: 10.1210/jcem.85.3.6441
Clinical Trial
Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany
N Krone et al. J Clin Endocrinol Metab. 2000 Mar.
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders. CAH is most often caused by deficiency of steroid 21-hydroxylase. The frequency of CYP21-inactivating mutations and the genotype-phenotype relationship were characterized in 155 well defined unrelated CAH patients. We were able to elucidate 306 of 310 disease-causing alleles (diagnostic sensitivity, 98.7%). The most frequent mutation was the intron 2 splice site mutation (30.3%), followed by gene deletions (20.3%), the I172N mutation (19.7%) and large gene conversions (7.1%). Five point mutations were detected that have not been described in other CAH cohorts. Genotypes were categorized in 4 mutation groups (null, A, B, and C) according to their predicted functional consequences and compared to the clinical phenotype. The positive predictive value for null mutations (ppv(null)) was 100%, as all patients with these mutations had a salt-wasting phenotype. In mutation group A (intron 2 splice site mutation in homozygous or heterozygous form with a null mutation), the ppv(A) to manifest with salt-wasting CAH was 90%. In group B predicted to result in simple virilizing CAH (I172N in homozygous or compound heterozygous form with a more severe mutation), ppv(B) was 74%. In group C (P30L, V281L, P453S in homozygous or compound heterozygous form with a more severe mutation), ppv(C) was 64.7% to exhibit the nonclassical form of CAH, but 90% when excluding the P30L mutation. Thus, in general, a good genotype-phenotype relationship is shown in patients with either the severest or the mildest mutations. A considerable degree of divergence is observed within mutation groups of intermediate severity. As yet undefined factors modifying 21-hydroxylase gene expression and steroid hormone action are likely to account for these differences in phenotypic expression.
Similar articles
- CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.
Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA. Stikkelbroeck NM, et al. J Clin Endocrinol Metab. 2003 Aug;88(8):3852-9. doi: 10.1210/jc.2002-021681. J Clin Endocrinol Metab. 2003. PMID: 12915679 - Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
Marino R, Ramirez P, Galeano J, Perez Garrido N, Rocco C, Ciaccio M, Warman DM, Guercio G, Chaler E, Maceiras M, Bergadá I, Gryngarten M, Balbi V, Pardes E, Rivarola MA, Belgorosky A. Marino R, et al. Clin Endocrinol (Oxf). 2011 Oct;75(4):427-35. doi: 10.1111/j.1365-2265.2011.04123.x. Clin Endocrinol (Oxf). 2011. PMID: 21609351 - The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia.
Dracopoulou-Vabouli M, Maniati-Christidi M, Dacou-Voutetakis C. Dracopoulou-Vabouli M, et al. J Clin Endocrinol Metab. 2001 Jun;86(6):2845-8. doi: 10.1210/jcem.86.6.7574. J Clin Endocrinol Metab. 2001. PMID: 11397897 - Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling.
Speiser PW. Speiser PW. Am J Pharmacogenomics. 2001;1(2):101-10. doi: 10.2165/00129785-200101020-00003. Am J Pharmacogenomics. 2001. PMID: 12174671 Review. - Association between genotype, clinical presentation, and severity of congenital adrenal hyperplasia: a review.
Al-Agha AE, Ocheltree AH, Al-Tamimi MD. Al-Agha AE, et al. Turk J Pediatr. 2012 Jul-Aug;54(4):323-32. Turk J Pediatr. 2012. PMID: 23692712 Review.
Cited by
- Genetics of 21-OH Deficiency and Genotype-Phenotype Correlation: Experience of the Hellenic National Referral Center.
Fylaktou I, Mertzanian A, Farakla I, Gryparis A, Vasilakis IA, Binou M, Charmandari E, Kanaka-Gantenbein C, Sertedaki A. Fylaktou I, et al. Curr Issues Mol Biol. 2024 Sep 24;46(10):10696-10713. doi: 10.3390/cimb46100635. Curr Issues Mol Biol. 2024. PMID: 39451515 Free PMC article. - Bone mineral density determinants in adolescents and young adults with congenital adrenal hyperplasia.
Navardauskaite R, Vanckaviciene A, Verkauskiene R. Navardauskaite R, et al. Front Pediatr. 2024 Oct 8;12:1456679. doi: 10.3389/fped.2024.1456679. eCollection 2024. Front Pediatr. 2024. PMID: 39439446 Free PMC article. - A capillary electrophoresis-based assay for carrier screening of the hotspot mutations in the CYP21A2 gene.
Tan J, Jin S, Huang L, Shao B, Wang Y, Wang Y, Zhang J, Su M, Tan J, Cheng Q, Xu Z. Tan J, et al. Heliyon. 2024 Sep 21;10(19):e38222. doi: 10.1016/j.heliyon.2024.e38222. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386847 Free PMC article. - Congenital Adrenal Hyperplasia - A Comprehensive Review of Genetic Studies on 21-Hydroxylase Deficiency from India.
Ravichandran L, Asha HS, Mathai S, Thomas N, Chapla A. Ravichandran L, et al. Indian J Endocrinol Metab. 2024 Mar-Apr;28(2):117-128. doi: 10.4103/ijem.ijem_303_23. Epub 2024 Apr 29. Indian J Endocrinol Metab. 2024. PMID: 38911104 Free PMC article. Review. - Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.
Gidlöf S, Hogling DE, Lönnberg H, Ritzén M, Lajic S, Nordenström A. Gidlöf S, et al. Horm Res Paediatr. 2024;97(5):445-455. doi: 10.1159/000535403. Epub 2023 Nov 28. Horm Res Paediatr. 2024. PMID: 38016434 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials